Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PROCTOSOL-HC 2.5% CREAM

Hydrocortisone
$0.6227per GM

Strength

25 mg/g

Manufacturer

Sun Pharmaceutical Industries Inc.

NDC

10631040701

Classification

Brand (ANDA)

Dosage Form

CREAM

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

HYDROCORTISONE

Approval Type

Generic (ANDA)

FDA Application

ANDA088799

On Market Since

4/28/2005

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price History

1W

0.0%

1M

+4.2%

3M

-51.1%

6M

-51.1%

1Y

-39.1%

3Y

-60.0%

5Y

-60.0%

All

+42.0%

Generic Alternatives

Save up to 90%

6 alternatives • Same active ingredient

HYDROCORTISONE 2.5% OINTMENT
Generic
45802001405•Padagis Israel Pharmaceuticals Ltd
$0.0642
Save 90%
HYDROCORTISONE 2.5% CREAM
Generic
51672300302•Sun Pharmaceutical Industries Inc.
$0.0817
Save 87%
HYDROCORTISONE 2.5% CREAM
Generic
00316019330•Crown Laboratories
$0.0860
Save 86%
HYDROCORTISONE 2.5% CREAM
Generic
00472033730•Actavis Pharma, Inc.
$0.0910
Save 85%
HYDROCORTISONE 2.5% CREAM
Generic
00168008031•E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
$0.0910
Save 85%
HYDROCORTISONE 2.5% CREAM
Generic
62559043130•ANI Pharmaceuticals, Inc.
$0.2347
Save 62%

Related Drugs

Same classification

ANUSOL-HC 2.5% CREAM
Brand
65649040130•Salix Pharmaceuticals Inc.
$3.2043
per GM
EPIFOAM FOAM
Brand
00037682410•Viatris Specialty LLC
$9.9995
per GM
NEO-SYNALAR 0.5%-0.025% CREAM
Brand
43538094060•Medimetriks Pharmaceuticals Inc.
$13.2101
per GM
PROCTOFOAM-HC 1%-1% FOAM
Brand
00037682210•Viatris Specialty LLC
$19.3978
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy